← Return to CEA and CA19-9 Results as Predictors of Treatment Outcome

Discussion

CEA and CA19-9 Results as Predictors of Treatment Outcome

Pancreatic Cancer | Last Active: Aug 16, 2023 | Replies (30)
Comment receiving replies
@ken240

I had been on Folferinox and now presently on Gemzar/Abraxane. For each treatment, excessive side effects were handled with either time off or dosage reduction or both. Have these options been considered?

Jump to this post

Replies to "I had been on Folferinox and now presently on Gemzar/Abraxane. For each treatment, excessive side effects..."
kjc12 | @kjc12 | Jul 17, 2023

Thank you. We’ll see what the “team” feels would be the best way to handle the next round. I will keep everything I am learning in my arsenal of questions for them❤️

VIEW AND REPLY